| Article
Jacques Cousteau said, “We forget that the water cycle and the life cycle are one." Water enriched with hydrogen molecules, which has had positive results when used as treatment in Alzheimer’s disease as well as depression, is now being studied for potential treatment of neurologic pain and its...
| Article
Neuropathic pain affects between 3% and 17% of the population. The journal Cureus offers a narrative review of neuropathic pain, stating that early and accurate diagnosis is paramount in improving pain control and outcomes. In this review, researchers provide updated information on neurological...
| Article
What are the best treatments for painful diabetic neuropathy? The American Academy of Neuropathy, with an endorsement by the American Association of Neuromuscular & Electrodiagnostic Medicine, has updated its 2011 guidelines for oral and topical treatments. The recommendations, which may reduce as...
| Article
Research published in the journal Human Movement Science examined whether those with diabetes, with or without neuropathy, would grip objects differently than healthy subjects. Those results were compared to patients with multiple sclerosis, carpal tunnel syndrome, and Parkinson’s. Highlights of...
| Article
Of the estimated 422 million adults with diabetes, approximately 20% will develop painful diabetic neuropathy. In an article published in JAMA Neurology, researchers outlined a study of inadequate relief from painful diabetic neuropathy and the potential of high frequency spinal cord stimulation...
| Article
A narrative review of minocycline—a 2nd-generation, semi-synthetic tetracycline used as a broad-spectrum antibiotic with anti-inflammatory properties—was performed by researchers evaluating its effectiveness in lessening neuropathic pain. Results were published in the Journal of Pain Research. A...
| Article
In an article in the PNAS journal, researchers report the power of 3 antibiotics against chronic pain, possibly reducing the need for opioids. The study abstract reports that “demeclocycline, chlortetracycline, and minocycline can be repurposed for treatment of neuropathic pain and potentially for...
| Article
Neuropathic pain—from an injury or disease of the peripheral and/or somatosensory nervous system—is usually severe and chronic, resistant to treatment, and therefore challenging for clinicians attempting to help patients. Researchers noted the high impact of neuropathic pain: "Many people with...
| Article
In a Journal of Nursing Scholarship article, published online ahead of print, type 2 diabetes patients experienced pain and fatigue reduction through relaxation and mindfulness techniques.
Click here for more information about mindfulness on PAINWeek.org.
Purpose: To examine the effects...
| Article
Newswise — Researchers from Joslin Diabetes Center, using a genome-wide association study, have identified a genetic factor linked to the development of diabetic peripheral neuropathy. This finding suggests a new target for preventive therapies. The research has been published online and will appear...